MiR-4270 acts as a tumor suppressor by directly targeting Bcl-xL in human osteosarcoma cells.
Veys C, Boulouard F, Benmoussa A, Jammes M, Brotin E, Rédini F, Poulain L, Gruchy N, Denoyelle C, Legendre F, Galera P.
Veys C, et al. Among authors: jammes m.
Front Oncol. 2023 Aug 31;13:1220459. doi: 10.3389/fonc.2023.1220459. eCollection 2023.
Front Oncol. 2023.
PMID: 37719019
Free PMC article.